All In MedTech

Device Trial Radar · NCT00359203

ISSUE3: International Study on Syncope of Uncertain Etiology 3

ISSUE3: International Study on Syncope of Uncertain Etiology 3 Pacemaker Therapy for Patients With Asystolic Neurally-mediated Syncope

Last checked: Nov 20, 2026Latest source record: Jul 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 511 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

511

Actual

Start

Sep 2006

Primary completion

Sep 2011

Study completion Nov 2012

Sponsor

Sponsor type
Industry
First posted
Aug 1, 2006

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

ISSUE 3 is a multi-center, prospective, randomised controlled double-blind study aimed to assess the effectiveness of pacemaker therapy for prevention of asystolic neurally-mediated syncope.

Conditions

  • Syncope

Interventions

  • Dual chamber pacemekerDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Syncope Recurrence RateTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medtronic Italia S.p.A.

    Rome, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.